Gurevich E, Abeles O, Landau D
Acta Paediatr. 2024; 114(2):364-369.
PMID: 39373280
PMC: 11706744.
DOI: 10.1111/apa.17436.
Takemasa Y, Fujinaga S, Nakagawa M, Sakuraya K, Hirano D
Pediatr Nephrol. 2023; 39(2):473-482.
PMID: 37608237
DOI: 10.1007/s00467-023-06108-4.
Barry A, McNulty M, Jia X, Gupta Y, Debiec H, Luo Y
Nat Commun. 2023; 14(1):2481.
PMID: 37120605
PMC: 10148875.
DOI: 10.1038/s41467-023-37985-w.
Geng H, Chen C, Tu J, Li H, DU P, Xia H
Zhongguo Dang Dai Er Ke Za Zhi. 2022; 24(8):853-857.
PMID: 36036121
PMC: 9425869.
DOI: 10.7499/j.issn.1008-8830.2203029.
Kalra S, Daryani H, Saxena A, Bhandari S, Sharma S
Med J Armed Forces India. 2022; 78(2):170-174.
PMID: 35463546
PMC: 9023548.
DOI: 10.1016/j.mjafi.2020.10.010.
Rates of idiopathic childhood nephrotic syndrome relapse are lower during the COVID-19 pandemic.
Crane C, Bakhoum C, Ingulli E
Pediatr Nephrol. 2022; 37(11):2679-2685.
PMID: 35211788
PMC: 8869345.
DOI: 10.1007/s00467-022-05483-8.
The role of the immune system in idiopathic nephrotic syndrome.
Hackl A, Abo Zed S, Diefenhardt P, Binz-Lotter J, Ehren R, Weber L
Mol Cell Pediatr. 2021; 8(1):18.
PMID: 34792685
PMC: 8600105.
DOI: 10.1186/s40348-021-00128-6.
Steroid treatment for the first episode of childhood nephrotic syndrome: comparison of the 8 and 12 weeks regimen using an individual patient data meta-analysis.
Schijvens A, Teeninga N, Dorresteijn E, Teerenstra S, Webb N, Schreuder M
Eur J Pediatr. 2021; 180(9):2849-2859.
PMID: 33774744
PMC: 8346453.
DOI: 10.1007/s00431-021-04035-w.
Practice variations in the management of childhood nephrotic syndrome in the Netherlands.
Schijvens A, van der Weerd L, van Wijk J, Bouts A, Keijzer-Veen M, Dorresteijn E
Eur J Pediatr. 2021; 180(6):1885-1894.
PMID: 33532891
PMC: 8105198.
DOI: 10.1007/s00431-021-03958-8.
Childhood risk factors for adulthood chronic kidney disease.
Stern-Zimmer M, Calderon-Margalit R, Skorecki K, Vivante A
Pediatr Nephrol. 2020; 36(6):1387-1396.
PMID: 32500249
DOI: 10.1007/s00467-020-04611-6.
CTLA4-Ig Abatacept Ameliorates Proteinuria by Regulating Circulating Treg/IL-17 in Adriamycin-Induced Nephropathy Rats.
Shuai L, Cheng Q, Shen T, Yi Z, Wu X
Biomed Res Int. 2020; 2020:2347827.
PMID: 32420329
PMC: 7201454.
DOI: 10.1155/2020/2347827.
Prediction of Short- and Long-Term Outcomes in Childhood Nephrotic Syndrome.
Carter S, Mistry S, Fitzpatrick J, Banh T, Hebert D, Langlois V
Kidney Int Rep. 2020; 5(4):426-434.
PMID: 32280840
PMC: 7136435.
DOI: 10.1016/j.ekir.2019.12.015.
Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic Syndrome.
Gipson D, Trachtman H, Waldo A, Gibson K, Eddy S, Dell K
Kidney Int Rep. 2020; 5(4):414-425.
PMID: 32280839
PMC: 7136430.
DOI: 10.1016/j.ekir.2019.11.018.
Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M
Pediatr Nephrol. 2019; 34(11):2417-2421.
PMID: 31435725
DOI: 10.1007/s00467-019-04339-y.
Prevalence rates of histopathologic subtypes associated with steroid resistance in childhood nephrotic syndrome in Sub-Saharan Africa: a systematic review.
Uwaezuoke S, Ndu I, Mbanefo N
Int J Nephrol Renovasc Dis. 2019; 12:167-176.
PMID: 31372025
PMC: 6627175.
DOI: 10.2147/IJNRD.S207372.
Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb N, Woolley R, Lambe T, Frew E, Brettell E, Barsoum E
BMJ. 2019; 365:l1800.
PMID: 31335316
PMC: 6531851.
DOI: 10.1136/bmj.l1800.
Childhood onset steroid-sensitive nephrotic syndrome continues into adulthood.
Korsgaard T, Andersen R, Joshi S, Hagstrom S, Rittig S
Pediatr Nephrol. 2018; 34(4):641-648.
PMID: 30426221
DOI: 10.1007/s00467-018-4119-8.
Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome.
Mizutani A, Fujinaga S, Sakuraya K, Hirano D, Shimizu T
Clin Exp Nephrol. 2018; 23(2):244-250.
PMID: 30121800
DOI: 10.1007/s10157-018-1628-5.
Treating the idiopathic nephrotic syndrome: are steroids the answer?.
Deschenes G, Dossier C, Hogan J
Pediatr Nephrol. 2018; 34(5):777-785.
PMID: 29869116
DOI: 10.1007/s00467-018-3963-x.
Predictive risk factors of steroid dependent nephrotic syndrome in children.
Abdel-Hafez M, Abou-El-Hana N, Erfan A, El-Gamasy M, Abdel-Nabi H
J Nephropathol. 2017; 6(3):180-186.
PMID: 28975099
PMC: 5607981.
DOI: 10.15171/jnp.2017.31.